Could shockwaves and magnets ease lymphedema? new trial aims to find out

NCT ID NCT06041958

Recruiting now Symptom relief Sponsor: Zheng-Yu Hoe, MD., PhD. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether two non-invasive therapies—extracorporeal shock wave therapy and pulse electromagnetic field therapy—can reduce swelling and improve quality of life in people with lymphedema after cancer treatment. Ninety participants will receive one of the therapies or standard rehabilitation twice a week for 12 weeks. The goal is to see if these treatments can safely reduce limb circumference, skin thickness, and tissue hardness.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Extracorporeal shock wave therapy and pulse electromagnetic field therapy (both devices)
What this could lead to: If successful, these therapies could offer a non-drug way to reduce limb swelling and improve daily function for people with lymphedema.
What could go wrong: This is an early-stage study with only 90 participants, and the therapies are not yet proven for lymphedema. Results may not apply to all patients, and benefits could be small or temporary.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LYMPHEDEMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

lymphedema

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

LYMPHEDEMA

Contacts and locations

Locations

Kaohsiung Veterans General Hospital
RECRUITING

Kaohsiung City, 81362, Taiwan

More trials for these conditions

Other studies related to the condition(s) this trial covers.